California wildfire smoke linked to 52,000 early deaths, study says

DavidMcNew/GettyImagesWhenlargeswathsoftheEastCoastwereshroudedinwildfiresmokelastsummer,scientistsi AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli




explore

author：hotspot    Page View：66464
Alexis Borisy
Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In
Previous article： NIH tests clinical research in primary care with $30 million program
Next article： Duchenne breakthrough therapy leaves behind pioneering families